Ikeda S, Ogawa H
Department of Dermatology, Juntendo University, School of Medicine, Tokyo, Japan.
J Invest Dermatol. 1991 Oct;97(4):644-8. doi: 10.1111/1523-1747.ep12483596.
Skin explants from two lesional areas and four normal-appearing areas of four patients with benign familial chronic pemphigus (BFCP) were organ cultured with and without various reagents. After 24-h culturing of involved skin with medium only, dissociation of keratinocytes, which was also observed prior to culturing, was exacerbated, and the epidermis became edematous, with a large section detaching from the dermis. These phenomena were not suppressed even when betamethasone, retinol acetate, or camostat mesilate (serine protease inhibitor) was added to the medium. On the other hand, in the cultures of uninvolved skin explants with medium only, widened intercellular spaces were observed 24-48 h after initiation of culture, and dissociation of keratinocytes and acantholytic clefts became apparent after 72 h. Such culture-induced acantholysis was almost completely suppressed by the addition of betamethasone, but not suppressed by the addition of retinol acetate, EDTA, N-ethylmaleimaide, or pepstatin A. Camostat and SBTI incompletely suppressed the acantholysis. These findings suggest the possibility that steroid may reduce blistering and that an organ culture of non-lesional benign familial chronic pemphigus (BFCP) skin may be useful for clarifying the pathogenesis, as well as for discovering new drugs for the treatment of BFCP. Further experiments are required to clarify the role of serine proteases in the acantholysis in this disease.
对4例良性家族性慢性天疱疮(BFCP)患者的两个病变部位及四个外观正常部位的皮肤外植体进行了添加和不添加各种试剂的器官培养。仅用培养基对受累皮肤进行24小时培养后,培养前就已观察到的角质形成细胞解离加剧,表皮出现水肿,大片表皮与真皮分离。即使在培养基中添加倍他米松、醋酸视黄醇或甲磺酸卡莫司他(丝氨酸蛋白酶抑制剂),这些现象也未得到抑制。另一方面,仅用培养基对未受累皮肤外植体进行培养时,培养开始后24 - 48小时观察到细胞间间隙增宽,72小时后角质形成细胞解离和棘层松解裂隙变得明显。这种培养诱导的棘层松解几乎完全被添加倍他米松所抑制,但添加醋酸视黄醇、乙二胺四乙酸(EDTA)、N - 乙基马来酰胺或胃蛋白酶抑制剂A并未抑制。卡莫司他和大豆胰蛋白酶抑制剂(SBTI)不完全抑制棘层松解。这些发现提示类固醇可能减少水疱形成,且非病变的良性家族性慢性天疱疮(BFCP)皮肤的器官培养可能有助于阐明发病机制以及发现治疗BFCP的新药。需要进一步实验来阐明丝氨酸蛋白酶在该疾病棘层松解中的作用。